1. Financial Results for Q2 and H1 FY27

The Board approved the unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026. The results were reviewed by the Audit Committee on October 28, 2026. The statutory auditor, Deloitte Haskins & Sells, issued an unmodified limited review report on both sets of results.

Consolidated Financial Highlights (All figures in ₹ millions, except per share data):

  • Q2 FY27 (Quarter ended Sept 30, 2026): Revenue from operations stood at ₹11,223; Total Income at ₹11,373; Profit Before Tax (PBT) at ₹1,474; Profit After Tax (PAT) at ₹1,123.
  • H1 FY27 (Six months ended Sept 30, 2026): Revenue from operations stood at ₹21,854; Total Income at ₹22,294; PBT at ₹3,001; PAT at ₹2,285.
  • Earnings Per Share (EPS): Basic EPS for Q2 FY27 was ₹4.67; Diluted EPS was ₹4.64. For H1 FY27, Basic EPS was ₹9.50; Diluted EPS was ₹9.44.
  • Assets & Liabilities (as of Sept 30, 2026): Total Assets stood at ₹46,933 million; Total Equity at ₹33,584 million; Total Liabilities at ₹13,349 million.

Standalone Financial Highlights (All figures in ₹ millions, except per share data):

  • Q2 FY27: Revenue from operations stood at ₹3,685; Total Income at ₹3,915; PBT at ₹783; PAT at ₹582.
  • H1 FY27: Revenue from operations stood at ₹7,092; Total Income at ₹7,661; PBT at ₹1,583; PAT at ₹1,181.
  • Earnings Per Share (EPS): Basic EPS for Q2 FY27 was ₹2.42; Diluted EPS was ₹2.40. For H1 FY27, Basic EPS was ₹4.91; Diluted EPS was ₹4.88.
  • Assets & Liabilities (as of Sept 30, 2026): Total Assets stood at ₹25,349 million; Total Equity at ₹21,575 million; Total Liabilities at ₹3,774 million.

The consolidated results include the financials of 1 subsidiary and 10 step-down subsidiaries whose interim financial information, reflecting total assets of ₹906 million and a net loss, was not reviewed by their auditors but was considered not material to the Group.

2. Allotment under Employee Stock Option Plans

The Board approved the allotment of equity shares under the RSU Scheme 2020 and ESOP Scheme 2020.

  • 50,009 shares were allotted under the RSU Scheme 2020.
  • 1,429 shares were allotted under the ESOP 2020 plan (without bonus element).
  • 756 shares were allotted under the ESOP 2020 plan (with bonus element).

The total number of securities allotted was 52,194 equity shares of face value ₹2 each.

3. Resignation of Director

Mr. Mark Francis Dzialga (DIN: 00955485) resigned from his position as Non-Executive Non-Independent Director, effective from the close of business hours on October 29, 2026. His resignation letter, dated October 14, 2026, stated the reason was the sale of the entire shareholding by Brighton Park Capital and its affiliates and was not due to any disagreement with the company.

4. Reconstitution of Board Committees

Consequent to the cessation of Mr. Dzialga, the Nomination and Remuneration Committee and the Investment Committee were reconstituted effective October 29, 2026.

  • Nomination and Remuneration Committee: Chairperson: Mr. Krishnamurthy Venugopala Tenneti; Members: Mr. Pravin Udhyavara Bhadya Rao, Mr. Jairaj Manohar Purandare, Dr. Ashish Gupta, Mr. Neeraj Bharadwaj.
  • Investment Committee: Chairperson: Mr. Krishnamurthy Venugopala Tenneti; Members: Dr. Ashish Gupta, Mr. Neeraj Bharadwaj, Dr. Rajesh Bhaskaran Nair, Ms. Jill Mary De Simone.

5. Resignation of Key Managerial Personnel (KMP)

Ms. Srishti Ramesh Kaushik (Membership No.: A21609) resigned from her positions as Company Secretary, Compliance Officer, and Key Managerial Personnel. Her resignation was accepted, and she will be relieved from her duties effective the close of business hours on December 02, 2026. She confirmed there were no material reasons for her resignation other than those stated in her letter.

6. Amendment to Internal Policy

The Board approved an amendment to the company's Prevention of Sexual Harassment Policy.

Other Information

  • The trading window for dealing in the company's securities by designated persons will reopen on Monday, November 02, 2026.
  • A final dividend of ₹2.25 per equity share for FY26 was paid on August 21, 2026, resulting in a cash outflow of ₹542 million.
  • The financial results and details of the board meeting outcomes are available on the company's website (https://www.indegene.com/) and the stock exchange websites.